Skip to Main Content
Center for Cancer ResearchCCR Home | About CCR | CCR Intranet

Headline Title

Medullary Thyroid Carcinoma

Multiple endocrine neoplasia (MEN) types 2A and 2B are rare genetic diseases, which lead to the development of medullary thyroid cancer, usually in childhood. Surgery is the only standard treatment. Patients with medullary thyroid cancer can be cured only by thyroidectomy, but only when it is performed at a time when the tumor is confined to the thyroid gland. Traditional chemotherapy is not effective in this cancer. The PET Section has developed a clinical trial with the targeted agent vandetanib for children and young adults with medullary thyroid carcinoma and is currently ongoing.

Dashed Line

In this section:

Clinical Trials
Contact Information
Dashed Line

return to the top

This Page Last Reviewed on July 21, 2014

About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility

A Service of the National Cancer Institute

Department of Health and Human Services National Institutes of Health (NIH) USA Gov